Listen Now!
Dermatology is always evolving, and if you haven’t caught the latest “Ask the Investigator” podcast episodes, you’re missing out on game-changing insights! Hosted by the always-engaging Dr. Adam Friedman and sponsored by La Roche-Posay, these trending podcasts tackle the future of acne treatment, the ongoing battle against dyspigmentation, and how to manage cutaneous side effects of targeted cancer therapies.
From Rx vs. OTC acne solutions to hyperpigmentation hacks and strategies for keeping cancer patients on life-saving treatments, these conversations are packed with clinical pearls you won’t want to miss.
Can’t-Miss Episodes
State of the Acne Management Union: Stud or Dud?
Acne R&D is fading faster than Marty McFly in that infamous family photo—but Dr. Hilary Baldwin isn’t giving up the fight just yet. Join her and Dr. Friedman as they dissect the future of acne management, the crucial role of OTC and Rx synergy, and how to address barrier dysfunction, scarring, and hyperpigmentation.
Diving into Dyspigmentation: Discoloration Details and Future Directions
Dyspigmentation can be just as frustrating as the disease that caused it—but fear not, Dr. Andrew Alexis is here to shine some much-needed light on practical treatment strategies. From managing patient expectations to the latest advancements, this episode delivers a full-spectrum discussion on hyperpigmentation care.
Treat to (Stay on) Target(ed Therapies)
New targeted cancer therapies are revolutionizing oncology—but their cutaneous side effects? Not so fun. Enter Dr. Jonathan Leventhal, who joins Dr. Friedman to break down the latest oncodermatology algorithms for keeping patients on treatment while minimizing dermatologic complications. Curl up with your favorite blanket and soak in the must-know strategies to keep your patients focused on fighting cancer—without unnecessary setbacks.
Don’t get left behind—tune in to these essential episodes now!
